Marinus Pharmaceuticals Launches the Ganaxolone Clinical Program in Patients with Postpartum Depression

June 27, 2017

Program to Evaluate Intravenous and Oral Ganaxolone in Patients with Severe or Moderate Postpartum Depression
More »

Esperion Announces FDA Confirmation of Regulatory Pathway to Approval for the Combination of Bempedoic Acid and Ezetimibe

June 26, 2017

Complementary, Non-statin, Oral Bempedoic Acid / Ezetimibe Combination Therapy Demonstrates 48% Lowering of LDL-C and Significant hsCRP Reduction with Potential for Lower Occurrence of Muscle-Related Side Effects
More »

Iterum Secures $65 Million in Series B Financing

May 19, 2017

Funding to support the Phase 3 clinical development of oral penem antibiotic
More »